Effects of Preplant and Postplant Rotary Hoe Use on Weed Control, Soybean Pod Position, and Soybean Yield

Demand for organic food products has consistently increased for more than 20 yr. The largest obstacle to organic soybean production in the southeastern United States is weed management. Current organic soybean production relies on mechanical weed control, including multiple postplant rotary hoe uses. Although postplant rotary hoe use is effective at the weed germination stage, its efficacy is severely compromised by delays due to weather. Preplant rotary hoeing is also a practice that has been utilized for weed control but the effectiveness of this practice to reduce the need for multiple postplant rotary hoeing for organic soybean production in the southeastern United States has not been investigated. Preplant rotary hoe treatments included a weekly rotary hoeing 4 wk before planting, 2 wk before planting, and none. Postplant rotary hoe treatments consisted of zero, one, two, three, and four postplant rotary hoe uses. Weed control was increased with preplant rotary hoeing at Plymouth in 2006 and 2007 but this effect disappeared with the first postplant rotary hoeing. Multiple postplant rotary hoe uses decreased soybean plant populations, decreased soybean canopy height, lowered soybean pod position, and decreased soybean yield. Plant mapping revealed that the percentage of total nodes and pods below 30 cm was increased by increased frequency of postplant rotary hoe use

Strategy as action: competitive dynamics and competitive advantage

Strategy as Action presents an action plan for how firms can build, improve, and defend their competitive advantage at every stage of their life cycle. For start-up firms entering a market, it provides a model for exploiting competitive uncertainty and blind spots; for growth firms who have established some market advantages, it provides an action plan for exploiting relative resources; for mature firms, it explains how to exploit market position; finally, for firms that have no decisive resource advantage, it provides an action plan based on firm co-operative reactions

Cutaneous cryptococcosis in solid organ transplant recipients

Clinical manifestations, treatment, and outcomes of cutaneous cryptococcosis in solid organ transplant (SOT) recipients are not fully defined. In a prospective cohort comprising 146 SOT recipients with cryptococcosis, we describe the presentation, antifungal therapy, and outcome of cutaneous cryptococcal disease. Cutaneous cryptococcosis was documented in 26/146 (17.8%) of the patients and manifested as nodular/ mass (34.8%), maculopapule (30.4%), ulcer/pustule/abscess (30.4%), and cellulitis (30.4%) with 65.2% of the skin lesions occurred in the lower extremities. Localized disease developed in 30.8% (8/26), and disseminated disease in 69.2% (18/26) with involvement of the central nervous system ( 88.9%, 16/18), lung (33.3%, 6/18 ), or fungemia (55.6%, 10/18). Fluconazole (37.5%) was employed most often for localized and lipid formulations of amphotericin B (61.1%) for disseminated disease. Overall mortality at 90 days was 15.4% (4/26) with 16.7% in disseminated and 12.5% in localized disease (P = 0.78). SOT recipients who died were more likely to have renal failure ( 75.0% vs. 13.6%, P = 0.028), longer time to onset of disease after transplantation (87.5 vs. 22.6 months, P = 0.023), and abnormal mental status (75% vs. 13.6%, P = 0.028) than those who survived. Cutaneous cryptococcosis represents disseminated disease in most SOT recipients and preferentially involves the extremities. Outcomes with appropriate management were comparable between SOT recipients with localized and disseminated cryptococcosis